As we head towards our virtual Symposium this year, we hear about the experiences from one of our international friends in the MND community, Silverio Conte, Chief of International Relations at Associazione conSLAncio Onlus.
Co-presented by Dr Merit Cudkowicz, from Harvard Medical School and Massachusetts General Hospital, and Dr Ralph Kern from BrainStorm Cell Therapeutics, this presentation discussed the keenly awaited results of the Phase 3 clinical trial of NurOwn.
It’s that time of year again. With just a week to go until the 31st International Symposium on ALS/MND, we thought we’d bring you an update on everything we’ve been doing to make sure we can still present the biggest scientific conference on ALS/MND in the world.
Are you curious about the research presented at our International Symposium on ALS/MND each year? Do you want to know more about current research in MND biomarkers, genomics, or stem cell and drug treatments for example?
For the first time, we are launching SympWatch videos as a new feature on our Periodic Table of MND Research resource. This is a selection of research presentations recorded from our last Symposium in Perth, Australia. Videos also feature useful ‘pop ups’ with information to help guide you through scientific language used by the researchers in the talks.
Check out our SympWatch trailer to see what research is to come (Sound on to hear the didgeridoo performance from the opening session).